Breaking News Instant updates and real-time market news.

JCOM

j2 Global

$73.78

-1.64 (-2.17%)

07:33
10/19/18
10/19
07:33
10/19/18
07:33

j2 Global initiated with an Outperform at Wedbush

Wedbush analyst Daniel Ives initiated j2 Global with an Outperform rating and $95 price target, telling investors in a research note that he believes the company remains a "misunderstood story" by the Street as the company is still painted by many investors as a legacy fax player, serial M&A machine, and has low growth prospects/high margins that have largely played out over the past few years with headwinds ahead.

  • 06

    Nov

JCOM j2 Global
$73.78

-1.64 (-2.17%)

02/02/18
DADA
02/02/18
INITIATION
Target $95
DADA
Buy
j2 Global initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated j2 Global with a Buy rating and a price target of $95, saying the company acquisition strategy is akin to private equity in "buying underperforming assets in cloud services and digital media and achieving scale through a roll-up strategy". The analyst is also positive on j2 Global's operating margin expansion and potential for further gains along with its attractive valuation relative to the peer group.
05/09/18
DADA
05/09/18
NO CHANGE
Target $100
DADA
Buy
j2 Global price target raised to $100 from $95 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on J2 Global to $100 after its Q1 earnings, saying the results were driven by a 16% revenue increase in digital media. The analyst notes that the segment is increasingly more focused on subscription revenue, which has grown to 22% of digital media's total sales from 12% last quarter, adding that EBITDA margins are also expected to improve after some compression in Q1. Jaluria keeps his Buy rating on J2 Global.
08/13/18
BARD
08/13/18
NO CHANGE
Target $92
BARD
Outperform
j2 Global weakness a buying opportunity, says Baird
Baird analyst William Power remains a buyer of j2 Global following its recent weakness. Power said while the display advertising market could continue to face challenges, he believes the growth areas within digital media, including its growing subscription business and accelerating fax trends, should help boost overall growth. Power reiterated his Outperform rating and lowered his price target to $92 from $95 on j2 Global shares.
10/18/18
WEDB
10/18/18
INITIATION
WEDB
Outperform
j2 Global initiated with an Outperform at Wedbush

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

, RAD

Rite Aid

$1.22

0.01 (0.83%)

08:50
11/19/18
11/19
08:50
11/19/18
08:50
Recommendations
Amazon.com, Rite Aid, Walgreens Boots Alliance, CVS Health analyst commentary  »

Jefferies uncovers signs…

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

RAD

Rite Aid

$1.22

0.01 (0.83%)

WBA

Walgreens Boots Alliance

$82.54

0.25 (0.30%)

CVS

CVS Health

$79.33

-0.48 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 02

    Dec

  • 04

    Dec

WP

Worldpay

$82.05

-0.62 (-0.75%)

08:50
11/19/18
11/19
08:50
11/19/18
08:50
Recommendations
Worldpay analyst commentary  »

Worldpay elevated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

08:50
11/19/18
11/19
08:50
11/19/18
08:50
General news
U.S. equities are back under pressure »

U.S. equities are back…

08:49
11/19/18
11/19
08:49
11/19/18
08:49
Conference/Events
Jefferies defense analysts to hold an analyst/industry conference call »

Defense Analysts provide…

RNG

RingCentral

$76.41

-0.54 (-0.70%)

08:49
11/19/18
11/19
08:49
11/19/18
08:49
Upgrade
RingCentral rating change  »

RingCentral upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$31.29

-0.1 (-0.32%)

08:47
11/19/18
11/19
08:47
11/19/18
08:47
Recommendations
Masco analyst commentary  »

Masco portfolio offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCON

TRACON Pharmaceuticals

$1.30

0.005 (0.39%)

08:46
11/19/18
11/19
08:46
11/19/18
08:46
Hot Stocks
TRACON Pharmaceuticals TRC102, Temodar trial does not meet primary endpoint »

TRACON Pharmaceuticals …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFR

Cullen/Frost

$101.35

0.11 (0.11%)

08:46
11/19/18
11/19
08:46
11/19/18
08:46
Conference/Events
Cullen/Frost has a conference call hosted by SunTrust »

SunTrust Analyst Demba…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PINC

Premier

$39.60

-0.26 (-0.65%)

08:45
11/19/18
11/19
08:45
11/19/18
08:45
Recommendations
Premier analyst commentary  »

Baird sees Premier shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$66.49

0.68 (1.03%)

, ACRX

AcelRx

$2.92

0.07 (2.46%)

08:45
11/19/18
11/19
08:45
11/19/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BAX

Baxter

$66.49

0.68 (1.03%)

ACRX

AcelRx

$2.92

0.07 (2.46%)

XOP

SPDR Oil Exploration and Production Fund

$34.75

-0.055 (-0.16%)

HEAR

Turtle Beach

$15.17

0.15 (1.00%)

NWL

Newell Brands

$21.69

0.32 (1.50%)

EBIX

Ebix

$51.54

1.83 (3.68%)

CNAT

Conatus

$4.82

0.16 (3.43%)

TRVN

Trevena

$0.64

-0.0056 (-0.87%)

EMR

Emerson

$69.68

0.86 (1.25%)

HUYA

Huya

$17.68

-0.45 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 05

    Dec

  • 11

    Dec

BB

BlackBerry

$8.97

0.12 (1.36%)

08:43
11/19/18
11/19
08:43
11/19/18
08:43
Upgrade
BlackBerry rating change  »

BlackBerry upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNN

Fusion

$2.42

-0.2 (-7.63%)

08:42
11/19/18
11/19
08:42
11/19/18
08:42
Hot Stocks
Fusion awarded $720,000 cloud solutions contract from Asian fast food chain »

Fusion announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

SFIX

Stitch Fix

$26.83

-0.09 (-0.33%)

08:41
11/19/18
11/19
08:41
11/19/18
08:41
Initiation
Stitch Fix initiated  »

Stitch Fix initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CARG

CarGurus

$38.76

0.31 (0.81%)

08:41
11/19/18
11/19
08:41
11/19/18
08:41
Initiation
CarGurus initiated  »

CarGurus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ATRA

Atara Biotherapeutics

$37.28

1.46 (4.08%)

08:39
11/19/18
11/19
08:39
11/19/18
08:39
Hot Stocks
Atara Biotherapeutics announces publication of Phase 1 ATA190 results »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

MBTF

MBT Financial

$11.25

0.03 (0.27%)

, FRME

First Merchants

$41.23

0.06 (0.15%)

08:39
11/19/18
11/19
08:39
11/19/18
08:39
Upgrade
MBT Financial, First Merchants rating change  »

Sandler O'Neill…

MBTF

MBT Financial

$11.25

0.03 (0.27%)

FRME

First Merchants

$41.23

0.06 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$3.83

0.095 (2.55%)

08:35
11/19/18
11/19
08:35
11/19/18
08:35
Hot Stocks
Adverum Biotechnologies announces first patient dosed in OPTIC trial »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

MLNX

Mellanox

$93.83

0.34 (0.36%)

, LN

Line Corp.

$28.48

-0.23 (-0.80%)

08:35
11/19/18
11/19
08:35
11/19/18
08:35
Hot Stocks
Line Corp. collaborates with Mellanox, Cumulus Networks for messaging platform »

Mellanox Technologies…

MLNX

Mellanox

$93.83

0.34 (0.36%)

LN

Line Corp.

$28.48

-0.23 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

08:35
11/19/18
11/19
08:35
11/19/18
08:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

FRME

First Merchants

$41.23

0.06 (0.15%)

08:33
11/19/18
11/19
08:33
11/19/18
08:33
Upgrade
First Merchants rating change  »

Sandler ONeill upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$115.51

-1.84 (-1.57%)

08:33
11/19/18
11/19
08:33
11/19/18
08:33
Recommendations
PVH Corp. analyst commentary  »

PVH Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

CLX

Clorox

$162.02

1.51 (0.94%)

08:31
11/19/18
11/19
08:31
11/19/18
08:31
Conference/Events
Clorox management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

08:31
11/19/18
11/19
08:31
11/19/18
08:31
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$101.29

1.56 (1.56%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$64.10

0.62 (0.98%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Conference/Events
Interxion management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.